Cumulatively, the above described studies clearly demonstrated that CIITA-driven MHC-II expressing tumor cells are strongly recognized in vivo and trigger tumor specific CD4+ TH cell responses that are protective against subsequent rechallenge with parental tumors. This evidence concerns the gene CD4 and neoplasm.